A tailored course, built for your situation
Mastering ICH GCP for Global Marketing Leaders in Adult Vaccines
A structured approach to aligning marketing governance with international clinical standards
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Marketing claims rejected due to misalignment with clinical trial compliance standards
The situation this course is for
Global campaigns are stalling at regional review gates because promotional language isn't calibrated to ICH GCP evidence thresholds. Teams are reworking materials last-minute, eroding credibility and launch timelines.
Who this is for
Global marketing executive in biopharma leading adult vaccine campaigns across regions, accountable for claim substantiation and regulatory alignment
Who this is not for
Regional field marketers, medical affairs generalists, or staff without governance responsibility in campaign validation
What you walk away with
- Map marketing claims directly to ICH GCP-aligned clinical evidence categories
- Lead cross-functional alignment sessions with legal, medical, and regulatory teams using shared terminology
- Anticipate regional review thresholds based on ICH GCP implementation depth
- Embed compliance readiness into campaign planning phases, reducing rework
- Strengthen executive visibility when cross-regional alignment succeeds
The 12 modules (with all 144 chapters)
Module 1. Understanding ICH GCP Core Principles in Marketing Context
Foundational knowledge of ICH GCP guidelines as they apply to promotional claims, including ethical standards, trial design transparency, and data integrity expectations. Focuses on real-world marketing implications rather than clinical operations.
12 chapters in this module
- Defining ICH GCP and its relevance to promotional claims
- How ICH GCP differs from general advertising regulations
- Core ethical principles in patient protection and trial conduct
- Linking marketing statements to trial protocol integrity
- Key sections of ICH E6 relevant to non-clinical teams
- Common misconceptions about GCP in commercial teams
- Case study: Marketing claim retracted due to GCP misalignment
- Jurisdictional variation in GCP interpretation for messaging
- The role of informed consent language in promotional materials
- Transparency expectations for efficacy data presentation
- Handling safety data in patient-facing campaigns
- Positioning relapse rates without misrepresenting trial outcomes
Module 2. Mapping Marketing Claims to Clinical Evidence
Technique for aligning promotional language with acceptable evidence tiers defined in ICH GCP. Enables confident assertion development backed by audit-ready documentation.
12 chapters in this module
- Classifying claim types by evidence requirements
- Identifying primary vs secondary endpoints in trial reports
- Translating statistical significance into consumer messaging
- Avoiding overstatement in durability and efficacy claims
- Using confidence intervals appropriately in visuals
- When to cite post-hoc analyses responsibly
- Handling subgroup findings without implying broad effect
- Referencing real-world evidence alongside RCTs
- Differentiating between clinical and statistical significance
- Aligning duration claims with study follow-up periods
- Incorporating adverse event rates truthfully
- Building claim hierarchies from strongest to weakest support
Module 3. Cross-Functional Alignment with Medical and Regulatory
Framework for leading alignment sessions with non-marketing stakeholders using shared standards. Strengthens influence across silos by establishing structured validation checkpoints.
12 chapters in this module
- Establishing joint review gates with medical affairs
- Creating a common language for claim substantiation
- Navigating disagreements on message interpretation
- Documenting consensus decisions on edge-case claims
- Timing marketing inputs with regulatory submission cycles
- Integrating safety update reviews into campaign refreshes
- Managing legacy materials when protocols change
- Building trust with compliance reviewers through consistency
- Running pre-submission alignment workshops
- Escalation paths for unresolved claim disputes
- Creating audit trails for campaign validation decisions
- Standardizing feedback language across regions
Module 4. Regional Implementation of ICH GCP Standards
Analysis of how ICH GCP is operationalized across key markets including US, EU, Japan, and emerging economies. Prepares leaders for jurisdiction-specific expectations in claim validation.
12 chapters in this module
- FDA’s interpretation of GCP in promotional contexts
- EMA’s stance on patient-reported outcomes in advertising
- PMDA requirements for data presentation in Japan
- Health Canada’s approach to indirect claims
- TGA guidelines on comparative efficacy language
- ANVISA’s restrictions on statistical representations
- SFDA expectations for local trial data inclusion
- Navigating undefined GCP policies in low-regulation markets
- Building flexible templates for high-compliance regions
- Managing translation impacts on claim precision
- Adapting visuals to meet regional evidence bars
- Tracking evolving GCP adoption in LATAM and ASEAN
Module 5. Claims Validation Workflow Design
Blueprint for integrating ICH GCP checks into marketing campaign lifecycle. Ensures compliance is embedded, not bolted on, reducing rework and delays.
12 chapters in this module
- Mapping the end-to-end campaign approval journey
- Inserting GCP checkpoints at creative inception
- Designing evidence review gates before copywriting
- Standardizing source documentation requirements
- Automating evidence-to-claim traceability
- Integrating legal and compliance reviews efficiently
- Creating version-controlled claim libraries
- Setting up periodic validation audits
- Managing updates when new data emerges
- Handling urgent campaign adjustments under GCP
- Training field teams on claim boundaries
- Documenting exceptions with governance approval
Module 6. Constructing Audit-Ready Substantiation Files
Method for assembling defensible documentation packages that satisfy internal and external reviewers. Ensures first-time pass in compliance audits.
12 chapters in this module
- Required elements of a claim substantiation dossier
- Organizing clinical references by claim hierarchy
- Annotating statistical results for non-expert reviewers
- Including protocol sections for context
- Referencing CONSORT and other reporting standards
- Archiving interim analyses with appropriate disclaimers
- Handling non-published data disclosures
- Redacting confidential details while preserving validity
- Versioning substantiation with campaign iterations
- Preparing files for cross-border regulatory requests
- Using timestamps and source verification
- Responding to auditor inquiries with precision
Module 7. Messaging Consistency Across Channels
Strategy for maintaining ICH GCP-aligned claims across digital, print, and sales materials. Prevents drift while enabling channel-specific adaptation.
12 chapters in this module
- Defining core message pillars with GCP guardrails
- Creating channel-specific expression rules
- Aligning digital banners with full-prescribing information
- Handling social media character limits responsibly
- Ensuring video scripts reflect trial parameters
- Training reps on verbal claim boundaries
- Auditing third-party content for compliance drift
- Managing influencer collaborations under GCP
- Using disclaimers effectively without undermining message
- Balancing patient engagement with scientific rigor
- Designing interactive tools within evidence limits
- Monitoring user-generated content implications
Module 8. Proactive Regulatory Engagement
Approach for engaging with regulators before submissions to shape expectations. Builds goodwill and reduces review cycle friction.
12 chapters in this module
- Identifying early engagement opportunities
- Preparing pre-submission packages with GCP focus
- Anticipating reviewer questions on claim logic
- Including negative study results transparently
- Framing real-world data within GCP context
- Addressing off-label use implications proactively
- Documenting rationale for borderline claims
- Using public statements to set expectations
- Responding to regulator feedback constructively
- Building relationships with review teams
- Sharing internal validation processes
- Positioning Pfizer as a compliance leader
Module 9. Crisis Response and Rapid Revalidation
Protocol for responding to safety alerts or study retractions that impact approved claims. Ensures swift, compliant updates across all markets.
12 chapters in this module
- Establishing triggers for claim revalidation
- Activating cross-regional crisis teams
- Assessing impact on existing promotional materials
- Prioritizing high-exposure channels for update
- Rewriting claims without creating new issues
- Communicating changes to field teams rapidly
- Updating digital assets at scale
- Preserving historical accuracy in corrections
- Managing media inquiries during revalidation
- Coordinating with pharmacovigilance teams
- Auditing updated materials for consistency
- Learning from incidents to improve future resilience
Module 10. Training and Enablement for Field Teams
System for scaling ICH GCP understanding across commercial teams. Ensures consistent execution without slowing velocity.
12 chapters in this module
- Assessing current team fluency with GCP concepts
- Developing tiered training for different roles
- Creating quick-reference claim guides
- Using interactive scenarios for reinforcement
- Testing knowledge retention effectively
- Incorporating GCP into onboarding programs
- Coaching managers to reinforce standards
- Gamifying compliance understanding
- Tracking field team error patterns
- Updating training with new regulatory feedback
- Measuring behavior change post-training
- Linking performance incentives to accuracy
Module 11. Benchmarking Against Industry Leaders
Analysis of how top biopharma companies implement ICH GCP in marketing. Provides concrete examples of effective governance models.
12 chapters in this module
- Reviewing Merck’s claim validation framework
- Analyzing GSK’s cross-functional workflows
- Learning from J&J’s regional adaptation strategy
- Studying Roche’s digital campaign compliance
- Comparing Novartis’ training approaches
- Evaluating AstraZeneca’s audit readiness
- Understanding Eli Lilly’s crisis response protocol
- Adopting Sanofi’s documentation standards
- Benchmarking claim approval cycle times
- Measuring rework reduction from best practices
- Adapting external successes to internal structure
- Building internal maturity models
Module 12. Future-Proofing Marketing Governance
Strategic foresight for anticipating next-phase ICH GCP developments and their marketing implications. Positions leaders ahead of regulatory shifts.
12 chapters in this module
- Tracking proposed ICH E6(R3) changes
- Preparing for increased real-world evidence scrutiny
- Anticipating AI-driven claims monitoring
- Adapting to decentralized trial data flows
- Integrating patient-centric endpoints responsibly
- Handling synthetic control arms in messaging
- Planning for longitudinal safety data claims
- Aligning with evolving digital health regulations
- Shaping internal policy before mandates arrive
- Leading industry dialogues on ethical promotion
- Positioning as a thought leader in compliant innovation
- Extending influence into next-gen product categories
How this maps to your situation
- Marketing campaign planning under ICH GCP scrutiny
- Cross-regional claim alignment in adult vaccines
- Regulatory review cycles for promotional materials
- Post-launch claim validation across diverse markets
Before vs. after
Before
Marketing claims face delays or rejection due to misalignment with ICH GCP expectations across regions.
After
Campaigns are launched with confidence, backed by audit-ready substantiation aligned with international standards.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45 minutes per module, designed for busy practitioners to complete over 8, 10 weeks with full flexibility.
If nothing changes
Continuing without structured ICH GCP integration risks repeated rework, regional non-compliance, and erosion of trust with regulatory partners.
How this compares to the alternatives
Unlike generic compliance courses, this program is tailored specifically to global vaccine marketing leaders, combining ICH GCP fluency with campaign governance , not just awareness, but operational mastery.
Frequently asked
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this relevant if I'm not in medical affairs?
Yes , it's designed specifically for global marketing leaders who must validate claims across regulatory environments.
Can I apply this across different vaccine portfolios?
Absolutely , the framework is built for transferability across adult vaccine categories and future product types.
$199 one-time. Approximately 45 minutes per module, designed for busy practitioners to complete over 8, 10 weeks with full flexibility..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours